Nalaganje...

Haploidentical transplantation using posttransplant cyclophosphamide as GVHD prophylaxis in patients over age 70

Hematologic malignancies in older people are unlikely to be cured with chemotherapy alone. Advances in allogeneic blood or marrow transplantation (alloBMT), especially nonmyeloablative (NMA) conditioning and the use of haploidentical donors, now make this therapy available to older people; however,...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Blood Adv
Main Authors: Imus, Philip H., Tsai, Hua-Ling, Luznik, Leo, Fuchs, Ephraim J., Huff, Carol Ann, Gladstone, Douglas E., Lowery, Patrick, Ambinder, Richard F., Borrello, Ivan M., Swinnen, Lode J., Wagner-Johnston, Nina, Gocke, Christian B., Ali, Syed Abbas, Bolaños-Meade, F. Javier, Varadhan, Ravi, Jones, Richard J.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2019
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6737415/
https://ncbi.nlm.nih.gov/pubmed/31492679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000155
Oznake: Označite
Brez oznak, prvi označite!